Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00126789
Status:
TERMINATED
Last Update Posted:
2012-06-05
First Post:
2005-08-02
Brief Title:
Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain
Sponsor:
ZARS Pharma Inc
Organization:
ZARS Pharma Inc
Organization Data
Organization:
ZARS Pharma Inc
Class:
INDUSTRY
Study ID:
ZMF-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ZARS Pharma Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None